Alaunos Therapeutics
TCRT
TCRT
122 hedge funds and large institutions have $356M invested in Alaunos Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.01% less ownership
Funds ownership: 0.28% → 0.27% (-0.01%)
5% less capital invested
Capital invested by funds: $376M → $356M (-$19.8M)
47% less call options, than puts
Call options by funds: $4.96M | Put options by funds: $9.29M
Holders
122
Holding in Top 10
2
Calls
$4.96M
Puts
$9.29M
Top Buyers
1 | +$2.81M | |
2 | +$1.98M | |
3 | +$872K | |
4 |
Goldman Sachs
New York
|
+$823K |
5 |
D.E. Shaw & Co
New York
|
+$764K |
Top Sellers
1 | -$16.8M | |
2 | -$2.12M | |
3 | -$1.46M | |
4 |
State Street
Boston,
Massachusetts
|
-$735K |
5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$710K |